Actinogen Medical Lists New Trading Options on ASX
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 13 2024
0mins
Source: Business Insider
Actinogen Medical Update: Actinogen Medical Limited is set to list 175.5 million options on the ASX under the code ACWOD, as part of an $8.9 million capital raising initiative, providing investors with a new trading opportunity in the biotechnology sector.
Investment Insights: The options will allow for direct trading on the ASX, potentially attracting stock enthusiasts looking for innovative investment avenues.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
